Derrick Rossi, Convelo Therapeutics
Scoop: Moderna co-founder's regenerative medicine biotech nabs funds, but loses Genentech
Moderna co-founder Derrick Rossi is back with additional financing for a Cleveland biotech that he’s been working on since 2017, but Convelo Therapeutics is moving forward without a Big Pharma partner.
The retired Boston Children’s Hospital professor and his co-founders at Case Western Reserve University have raised nearly $11 million for Convelo in a new equity round, according to an SEC filing last week. Genentech is no longer part of the picture, though.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters